Alcohol use and consequences in matriculating US college students by prescription stimulant/opioid nonmedical misuse status.

Journal Article (Journal Article)

BACKGROUND: US college students have elevated prescription opioid and stimulant misuse rates, with frequent alcohol use and alcohol-related consequences (ARCs). To date, though, no research has examined relationships between opioid and/or stimulant misuse and alcohol quantity/frequency or ARC variables in college students. METHODS: The 2016-17 AlcoholEDU for College™, a web-based alcohol prevention program, provided data (n = 491,849). Participants were grouped into past 14-day: (1) no misuse; (2) opioid misuse only; (3) stimulant misuse only; and (4) combined misuse. Using multilevel logistic regressions, groups were compared on 14-day alcohol use odds, and among those with use, odds of any ARCs and specific ARCs (e.g., hangover). Multilevel negative binomial regressions compared group members with alcohol use on 14-day total drinks, maximum 24-h drinks and drinking days. RESULTS: Alcohol use and any ARCs odds were highest in the stimulant (odds ratios [OR] = 3.47 and 2.97, respectively) or opioid misuse only groups (ORs = 3.31 and 2.43, respectively), with the combined misuse group intermediate (ORs = 1.63 and 1.29; reference: no misuse). Mean 14-day drinks decreased from those with combined misuse, to those with stimulant misuse only, opioid misuse only and no misuse (8.22, 7.1, 6.67, and 4.71, respectively). CONCLUSIONS: College students engaged in 14-day stimulant and/or opioid misuse had higher odds of 14-day alcohol use, higher levels of alcohol use, and a greater likelihood of ARCs, versus students without misuse. These findings suggest that college students with any prescription misuse need alcohol screening, although those with poly-prescription misuse may not need more intensive alcohol interventions.

Full Text

Duke Authors

Cited Authors

  • Schepis, TS; Acheson, S; Zapp, D; Swartzwelder, HS

Published Date

  • November 2019

Published In

Volume / Issue

  • 98 /

Start / End Page

  • 106026 -

PubMed ID

  • 31415970

Pubmed Central ID

  • PMC6754780

Electronic International Standard Serial Number (EISSN)

  • 1873-6327

Digital Object Identifier (DOI)

  • 10.1016/j.addbeh.2019.06.015


  • eng

Conference Location

  • England